SDC1 and plasma cell myeloma: CD138+ (myeloma plasma cells) and CD138– (non-malignant cells) cells were isolated from bone marrow samples obtained from eight myeloma patients (Table 1) and treated with 25 μM amuvatinib for 24 h.